However, in order to test new scientific approaches in human clinical trials breaking through the putative resistance of endogenous leptin in obesity, the mechanisms of action and signalling pathways of leptin remain to be fully determined. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.